820 for medical devices and 21 CFR Part 211 for pharmaceuticals. In the EU, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) provide similar guidelines.

Objectives: The primary objective of this step is to familiarize yourself with the regulations that dictate how SOPs, CAPAs, and audits must be structured and maintained. This foundational knowledge is crucial for compliance and for avoiding common inspection findings.

Key Documents: Key documents to review include:

• FDA Guidance Documents
• ISO 13485:2016 for Quality Management Systems
• ICH Q10 for Pharmaceutical Quality Systems

Responsible Roles: Quality managers and regulatory affairs professionals should take the lead in this phase, ensuring that all team members are aware of the relevant regulations.

Common Inspection Findings: Common findings during inspections often include inadequate understanding of regulatory requirements, leading to non-compliance in documentation practices. For example, the FDA may cite a manufacturer for failing to maintain adequate records of CAPA investigations.

Step 2: Developing SOPs for Document Control

Once you have a solid understanding of the regulatory landscape, the next step is to develop Standard Operating Procedures (SOPs) for document control. SOPs are critical for ensuring that all documents are created, reviewed, approved, and maintained in a controlled manner.

Objectives: The goal here is to establish a clear process for document management that aligns with regulatory expectations. This includes defining how documents are created, updated, and archived.

Key Documents: Essential documents in this phase include:

• Document Control SOP
• Template for SOPs
• Document Review and Approval Forms

Responsible Roles: Document control specialists and quality managers should collaborate to draft and implement these SOPs, ensuring that all team members are trained on the new processes.

Common Inspection Findings: Inspectors often find issues related to document control, such as missing signatures on approval forms or outdated versions of documents being used in practice. For instance, the EMA may highlight discrepancies in the version control of SOPs during audits.

Step 3: Implementing CAPA Processes

Corrective and Preventive Actions (CAPA) are vital for addressing non-conformities and preventing their recurrence. This step involves establishing a robust CAPA process that complies with FDA and ISO standards.

Objectives: The objective is to create a systematic approach for identifying, investigating, and resolving quality issues. This process should also include preventive measures to mitigate future risks.

Key Documents: Important documents for this step include:

• CAPA Procedure
• CAPA Investigation Report Template
• CAPA Effectiveness Check Form

Responsible Roles: Quality assurance teams, along with department heads, should be involved in the CAPA process to ensure comprehensive investigations and effective resolutions.

Common Inspection Findings: Common findings related to CAPA include inadequate root cause analysis and failure to implement corrective actions effectively. For example, the FDA may cite a company for not adequately documenting the effectiveness of a CAPA, leading to repeated issues.

Step 4: Conducting Internal Audits

Internal audits are essential for evaluating the effectiveness of your QMS and ensuring compliance with regulatory requirements. This step focuses on developing an internal audit program that aligns with ISO 13485 and FDA expectations.

Objectives: The main objective is to systematically assess compliance with established SOPs, CAPA processes, and overall QMS effectiveness. This proactive approach helps identify areas for improvement before external audits occur.

Key Documents: Key documents for internal audits include:

• Internal Audit Procedure
• Audit Checklist Template
• Audit Report Template

Responsible Roles: Internal auditors, quality managers, and department heads should collaborate to conduct audits and review findings collectively.

Common Inspection Findings: Common findings during audits often include incomplete audit trails and insufficient follow-up on audit findings. For instance, the MHRA may note a lack of action taken on identified non-conformities during their inspections.

Step 5: Training and Competence Assessment

Training is a critical component of maintaining a compliant QMS. This step involves developing a training program that ensures all employees are competent in their roles and understand the importance of SOPs, CAPA, and audits.

Objectives: The objective is to ensure that all personnel are adequately trained and competent to perform their tasks in compliance with regulatory requirements.

Key Documents: Essential documents for this phase include:

• Training Procedure
• Training Records Template
• Competence Assessment Form

Responsible Roles: Training coordinators and quality managers should oversee the development and implementation of the training program, ensuring that all employees receive the necessary training.

Common Inspection Findings: Common findings related to training often include inadequate documentation of training records and failure to assess employee competence effectively. For example, the FDA may cite a company for not providing sufficient training on new SOPs, leading to non-compliance.

Step 6: Continuous Improvement and Management Review

The final step in this process is to establish a culture of continuous improvement and conduct regular management reviews of the QMS. This phase is essential for ensuring that the QMS remains effective and compliant over time.

Objectives: The goal is to create a framework for ongoing evaluation and enhancement of the QMS, ensuring that it adapts to changes in regulations, technology, and organizational needs.

Key Documents: Key documents for this step include:

• Management Review Procedure
• Continuous Improvement Plan Template
• QMS Performance Metrics Report

Responsible Roles: Senior management and quality managers should lead the management review process, ensuring that all relevant data is analyzed and discussed.

Common Inspection Findings: Common findings during management reviews often include a lack of actionable insights from performance metrics and insufficient follow-up on improvement initiatives. For example, the EMA may highlight a failure to address trends in non-conformities during their assessments.